Who owns the LEALING BIOPHARMA trademark?

The LEALING BIOPHARMA trademark is owned by Liling biopharmaceuticals (Suzhou) Co., Ltd.

What class is the LEALING BIOPHARMA trademark registered in?

The LEALING BIOPHARMA trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for LEALING BIOPHARMA?

The USPTO serial number for LEALING BIOPHARMA is 90860167.

What is the registration number for LEALING BIOPHARMA?

LEALING BIOPHARMA is registered under USPTO registration number 6825724.

LEA

USPTO Trademark Record

REGISTERED

LEALING BIOPHARMA

SN 90860167·Reg 6825724·Filed Aug 02, 2021

Owner Liling biopharmaceuticals (Suzhou) Co., Ltd

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

LEALING BIOPHARMA (Serial No. 90860167), Registration No. 6825724, is a registered US trademark filed on Aug 02, 2021 by Liling biopharmaceuticals (Suzhou) Co., Ltd. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: August 23, 2028

Mark Intelligence

LEALING BIOPHARMA (Reg. #6825724) is a registered US trademark that has been protecting its owner, Liling biopharmaceuticals (Suzhou) Co., Ltd, since 2021. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Aug 02, 2021

SERIAL

90860167

REG#

6825724

REGISTERED

Aug 23, 2022

Owner

Applicant

Liling biopharmaceuticals (Suzhou) Co., Ltd

Entity

Not Provided

Address

Room 502, Building 1, Shunda Commercial, Plaza, Suzhou Industrial Park,, Jiangsu, 215000

Country

Attorney

Law firm

Liling biopharmaceuticals (Suzhou) Co., Ltd

Address

Room 502, Building 1, Shunda Commercial, Plaza, Suzhou Industrial Park,, Jiangsu, 215000, CHINA

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateAug 02, 2021

Serial Number90860167

Registration No.6825724

Registration DateAug 23, 2022

Status DateAug 23, 2022

Published for OppositionJun 07, 2022

Mark TypeStandard characters

Status DescriptionLive and registered

Filing Signals

FILED

2021

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Jul 31, 2021

First use in commerce: Jul 31, 2021

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

15 events

TEAS WITHDRAWAL OF ATTORNEY RECEIVED

Jan 11, 2025

TEAS WITHDRAWAL OF ATTORNEY RECEIVED

WITHDRAWAL OF ATTORNEY GRANTED

Jan 11, 2025

WITHDRAWAL OF ATTORNEY GRANTED

REGISTERED-PRINCIPAL REGISTER

Aug 23, 2022

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Aug 23, 2022

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Jun 07, 2022

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jun 07, 2022

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

May 18, 2022

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

May 05, 2022

APPROVED FOR PUB - PRINCIPAL REGISTER

EXAMINERS AMENDMENT -WRITTEN

May 03, 2022

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

May 03, 2022

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

May 03, 2022

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

May 03, 2022

EXAMINER'S AMENDMENT ENTERED

ASSIGNED TO EXAMINER

Apr 29, 2022

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 28, 2021

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Aug 05, 2021

NEW APPLICATION ENTERED

LEALING BIOPHARMA

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Liling biopharmaceuticals (Suzhou) Co., Ltd

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Resources

Company